Cambridge Cog Regulatory News (COG)

Cambridge Cognition Holdings plc

("Cambridge Cognition" or the "Company")

Investor Presentation

Cambridge Cognition Holdings plc (AIM: COG), which develops and markets digital solutions to assess brain health, is pleased to announce that CEO Matthew Stork and CFO Michael Holton will provide a live investor presentation on Tuesday 23 March at 6.00 p.m. London time. This follows the anticipated release of the Company's preliminary results for the year ended 31 December 2020 at 7:00 a.m. on 23 March 2021.

The presentation is open to all existing and potential shareholders. Those wishing to attend should email cog@investor-focus.co.uk and they will be provided with log in details. There will be the opportunity for participants to ask questions at the end of the presentation. Questions can also be emailed to the above address ahead of the presentation.

Enquiries:

Notes to Editors

About Cambridge Cognition

Cambridge Cognition is a technology company developing digital products to better understand, detect and treat conditions affecting brain health. The Company's software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early and improve global efficiency in pharmaceutical and healthcare industries.

For further information visit www.cambridgecognition.com